Table 2. Summary of literature on mortality and progression to ESRD in CKD stage 4.
Study | Mean age (years) | GFR (ml/min) | Progression to ESRD | Mortality | Population |
Keith (2001) | 73.6±13.6 | 15–29 | 19.9%* | 45.7%* | Large HMO |
Go (2004) | 70.1±14.5 | 15–29 | 11.36 per 100 PY‡ | Large HMO | |
Patel (2005) | 70.0±10.0 | 15–29 | 14.2 per 100 PY | 20.1 per 100 PY | Veterans |
O'Hare (2007) | 65–74 | 15–29 | 9.31 per 100 PY | 11.68 per 100 PY | Veterans |
O'Hare (2007) | 75–84 | 15–29 | 6.31 per 100 PY | 15.39 per 100 PY | Veterans |
Roderick (2009) | 83.2±7.1 | <30 | 19–29 per 100 PY | UK General Practice | |
Keough-Ryan (2008) | 69.2±13.2 | <30 | 4.27 per 100 PY | 33.45 per 100 PY | Post acute cardiac event |
Levin (2008) | 66.8±14.5 | <30 | 14.3 per 100 PY | 4.5 per 100 PY | Referred population |
Conway (2009) | Median 71.6 | <30 | 3.8%† | 10.4%† | Referred population |
*crude data in percentages, over 66 months of follow up.
crude 1 year data in percentages.
Age-Standardized Rates.
PY: patient-years.
HMO: Health Maintenance Oraganization.